Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)

NCT01058915 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Rosuvastatin 5mg
DRUG: Rosuvastatin 40mg

Sponsor

Odense University Hospital